Peptide receptor radionuclide therapy (PRRT) in European Neuroendocrine Tumour Society (ENETS) grade 3 (G3) neuroendocrine neoplasia (NEN) - a single-institution retrospective analysis

Debating Best First-Line Treatment in Well-Differentiated G3 NENs

AJMC, 06 Oct 2018

During a session at the North American Neuroendocrine Tumor Society annual meeting October 4-6 in Seattle, Washington…